SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-23-018675
Filing Date
2023-04-17
Accepted
2023-04-17 16:39:19
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny200066998x2_defa14a.htm DEFA14A 9963
2 logo_appliedtherapeutics.jpg GRAPHIC 31301
3 ny20006698x2_nc1.jpg GRAPHIC 1874340
4 ny20006698x2_nc2.jpg GRAPHIC 923877
  Complete submission text file 0001140361-23-018675.txt   3598151
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38898 | Film No.: 23824405
SIC: 2834 Pharmaceutical Preparations